ID CDK20_MOUSE Reviewed; 346 AA. AC Q9JHU3; Q5EDC2; DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 24-JAN-2024, entry version 157. DE RecName: Full=Cyclin-dependent kinase 20; DE EC=2.7.11.22; DE AltName: Full=CDK-activating kinase p42; DE Short=CAK-kinase p42; DE AltName: Full=CDK-related protein kinase PNQLARE; DE AltName: Full=Cell cycle-related kinase; DE AltName: Full=Cell division protein kinase 20; DE AltName: Full=Cyclin-dependent protein kinase H; DE AltName: Full=Cyclin-kinase-activating kinase p42; GN Name=Cdk20; Synonyms=Ccrk, Cdch; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=129/SvJ; RA Liao J.C., Fisher R.P.; RT "PNQALRE a novel member of the CDK family."; RL Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2). RC STRAIN=C57BL/6J; TISSUE=Heart; RA Qiu H., Depre C.; RT "Mouse p42(CCRK), cardiac variant."; RL Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Eye; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, INTERACTION WITH TBC1D32, IDENTIFICATION BY MASS SPECTROMETRY, RP AND SUBCELLULAR LOCATION. RX PubMed=20159594; DOI=10.1016/j.devcel.2009.12.014; RA Ko H.W., Norman R.X., Tran J., Fuller K.P., Fukuda M., Eggenschwiler J.T.; RT "Broad-minded links cell cycle-related kinase to cilia assembly and RT hedgehog signal transduction."; RL Dev. Cell 18:237-247(2010). CC -!- FUNCTION: Involved in cell growth. Activates CDK2, a kinase involved in CC the control of the cell cycle, by phosphorylating residue 'Thr-160' (By CC similarity). Required for high-level Shh responses in the developing CC neural tube. Together with TBC1D32, controls the structure of the CC primary cilium by coordinating assembly of the ciliary membrane and CC axoneme, allowing GLI2 to be properly activated in response to SHH CC signaling. {ECO:0000250, ECO:0000269|PubMed:20159594}. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl- CC [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA- CC COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22; CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L- CC threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, CC Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; CC EC=2.7.11.22; CC -!- SUBUNIT: Monomer (By similarity). Interacts with MAK (By similarity). CC Interacts with TBC1D32. {ECO:0000250, ECO:0000269|PubMed:20159594}. CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:20159594}. Cytoplasm CC {ECO:0000269|PubMed:20159594}. Cell projection, cilium CC {ECO:0000269|PubMed:20159594}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9JHU3-1; Sequence=Displayed; CC Name=2; Synonyms=Cardiac CCRK; CC IsoId=Q9JHU3-2; Sequence=VSP_016753, VSP_016754; CC -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr CC protein kinase family. CDC2/CDKX subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AY005133; AAF89089.1; -; mRNA. DR EMBL; AY904369; AAW82351.1; -; mRNA. DR EMBL; BC031907; AAH31907.1; -; mRNA. DR CCDS; CCDS26601.1; -. [Q9JHU3-1] DR RefSeq; NP_444410.1; NM_053180.2. [Q9JHU3-1] DR AlphaFoldDB; Q9JHU3; -. DR SMR; Q9JHU3; -. DR STRING; 10090.ENSMUSP00000021939; -. DR iPTMnet; Q9JHU3; -. DR PhosphoSitePlus; Q9JHU3; -. DR jPOST; Q9JHU3; -. DR MaxQB; Q9JHU3; -. DR PaxDb; 10090-ENSMUSP00000021939; -. DR ProteomicsDB; 281435; -. [Q9JHU3-1] DR ProteomicsDB; 281436; -. [Q9JHU3-2] DR Pumba; Q9JHU3; -. DR Antibodypedia; 27918; 375 antibodies from 30 providers. DR DNASU; 105278; -. DR Ensembl; ENSMUST00000021939.8; ENSMUSP00000021939.7; ENSMUSG00000021483.9. [Q9JHU3-1] DR GeneID; 105278; -. DR KEGG; mmu:105278; -. DR UCSC; uc007qyx.1; mouse. [Q9JHU3-1] DR AGR; MGI:2145349; -. DR CTD; 23552; -. DR MGI; MGI:2145349; Cdk20. DR VEuPathDB; HostDB:ENSMUSG00000021483; -. DR eggNOG; KOG0659; Eukaryota. DR GeneTree; ENSGT00940000159128; -. DR HOGENOM; CLU_000288_181_1_1; -. DR InParanoid; Q9JHU3; -. DR OMA; KITFPYH; -. DR OrthoDB; 244018at2759; -. DR PhylomeDB; Q9JHU3; -. DR TreeFam; TF327240; -. DR BRENDA; 2.7.11.22; 3474. DR BioGRID-ORCS; 105278; 3 hits in 81 CRISPR screens. DR ChiTaRS; Cdk20; mouse. DR PRO; PR:Q9JHU3; -. DR Proteomes; UP000000589; Chromosome 13. DR RNAct; Q9JHU3; Protein. DR Bgee; ENSMUSG00000021483; Expressed in primary oocyte and 123 other cell types or tissues. DR ExpressionAtlas; Q9JHU3; baseline and differential. DR GO; GO:0005929; C:cilium; IEA:UniProtKB-SubCell. DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell. DR GO; GO:0005654; C:nucleoplasm; ISO:MGI. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0004693; F:cyclin-dependent protein serine/threonine kinase activity; IEA:UniProtKB-EC. DR GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA. DR GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central. DR GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW. DR GO; GO:0051301; P:cell division; IEA:UniProtKB-KW. DR GO; GO:1990403; P:embryonic brain development; IMP:MGI. DR GO; GO:0031076; P:embryonic camera-type eye development; IMP:MGI. DR GO; GO:0048706; P:embryonic skeletal system development; IMP:MGI. DR GO; GO:0021508; P:floor plate formation; IMP:MGI. DR GO; GO:0045879; P:negative regulation of smoothened signaling pathway; IGI:MGI. DR GO; GO:0001843; P:neural tube closure; IMP:MGI. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0061512; P:protein localization to cilium; IMP:MGI. DR GO; GO:1903317; P:regulation of protein maturation; IMP:MGI. DR GO; GO:0008589; P:regulation of smoothened signaling pathway; IGI:MGI. DR GO; GO:0060021; P:roof of mouth development; IMP:MGI. DR CDD; cd07832; STKc_CCRK; 1. DR Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1. DR InterPro; IPR048002; CDK20-like_STKc. DR InterPro; IPR011009; Kinase-like_dom_sf. DR InterPro; IPR000719; Prot_kinase_dom. DR InterPro; IPR017441; Protein_kinase_ATP_BS. DR InterPro; IPR008271; Ser/Thr_kinase_AS. DR PANTHER; PTHR24056; CELL DIVISION PROTEIN KINASE; 1. DR PANTHER; PTHR24056:SF171; CYCLIN-DEPENDENT KINASE 20; 1. DR Pfam; PF00069; Pkinase; 1. DR SMART; SM00220; S_TKc; 1. DR SUPFAM; SSF56112; Protein kinase-like (PK-like); 1. DR PROSITE; PS00107; PROTEIN_KINASE_ATP; 1. DR PROSITE; PS50011; PROTEIN_KINASE_DOM; 1. DR PROSITE; PS00108; PROTEIN_KINASE_ST; 1. DR Genevisible; Q9JHU3; MM. PE 1: Evidence at protein level; KW Alternative splicing; ATP-binding; Cell cycle; Cell division; KW Cell projection; Cilium; Cytoplasm; Developmental protein; Kinase; KW Nucleotide-binding; Nucleus; Reference proteome; KW Serine/threonine-protein kinase; Transferase. FT CHAIN 1..346 FT /note="Cyclin-dependent kinase 20" FT /id="PRO_0000085703" FT DOMAIN 4..288 FT /note="Protein kinase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT REGION 298..324 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 298..316 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 127 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159, FT ECO:0000255|PROSITE-ProRule:PRU10027" FT BINDING 10..18 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT BINDING 33 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00159" FT VAR_SEQ 168..243 FT /note="WYRAPELLYGARQYDQGVDLWAVGCIMGELLNGSPLFPGENDIEQLCCVLRI FT LGTPSPRVWPEITELPDYNKISFK -> SSLSCRTTTRSPLRSRCPCPWRRCCLTSLPR FT HWICWVNSFSTLLTSASQLPRLSSISTSSQLPCLPIHLSCRFLSV (in isoform FT 2)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_016753" FT VAR_SEQ 244..346 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|Ref.2" FT /id="VSP_016754" FT CONFLICT 44 FT /note="I -> F (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" FT CONFLICT 58 FT /note="I -> M (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" FT CONFLICT 61 FT /note="S -> N (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" FT CONFLICT 75 FT /note="A -> G (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" FT CONFLICT 101 FT /note="P -> Q (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" FT CONFLICT 157 FT /note="G -> S (in Ref. 2; AAW82351)" FT /evidence="ECO:0000305" SQ SEQUENCE 346 AA; 38379 MW; ACCACE0C3FC4B833 CRC64; MDQYCILGRI GEGAHGIVFK AKHVETGEIV ALKKVALRRL EDGIPNQALR EIKALQEIED SQYVVQLKAV FPHGAGFVLA FEFMLSDLAE VVRHAQRPLA PAQVKSYLQM LLKGVAFCHA NNIVHRDLKP ANLLISASGQ LKIADFGLAR VFSPDGGRLY THQVATRWYR APELLYGARQ YDQGVDLWAV GCIMGELLNG SPLFPGENDI EQLCCVLRIL GTPSPRVWPE ITELPDYNKI SFKEQAPVPL EEVLPDASPQ ALDLLGQFLL YPPRQRIAAS QALLHQYFFT APLPAHPSEL PIPQRPGGPA PKAHPGPPHV HDFHVDRPLE ESLLNPELIR PFIPEG //